Smith & Nephew Birmingham Resurfacing premature hip failure. Many metal hip manufacturers have been under fire for the past decade over the premature failure of their metal on metal hip designs.
Smith & Nephew Urgent Field Safety Recall Notice
Dr Shezad Malik Law Firm has offices based in Fort Worth and Dallas and represents people who have suffered catastrophic and serious personal injuries including wrongful death, caused by the negligence or recklessness of others. We specialize in Personal Injury trial litigation and focus our energy and efforts on those we represent.
Smith & Nephew Birmingham Resurfacing premature hip failure. Many metal hip manufacturers have been under fire for the past decade over the premature failure of their metal on metal hip designs.
Smith & Nephew Urgent Field Safety Recall Notice
Total Number of DePuy ASR Settlements Exceeds 9,400 Cases
Johnson and Johnson (J&J) and its subsidiary DePuy Orthopaedics, has agreed to add another 1,400 hip injury claims to a settlement agreement reached in 2013. This new agreement extends the deal to include recalled ASR implants that were revised as of January 31, 2015.
This extension, provides further relieve to injured plaintiffs who were locked out of the original settlement, which cut off claims as of August 2013.
Total Number of Settlements Exceeds 9,400 Cases
Johnson & Johnson Settlement Details
Smith & Nephew recently issued a safety notice that indicates the Birmingham hip failure rate appears to be higher than 1%, which exceeds the rate established for quality standards according to the United Kingdom’s National Institute for Health and Clinical Excellence.
According to data collected since 2010 in the National Joint Registry of England and Wales, as well as the Australian Orthopaedic Associations National Joint Replacement Registry, the rate of Smith & Nephew Birmingham hip problems that were classified as a failure were 1.29% and 1.12%, respectively.
Johnson & Johnson Under Fire from Lawsuits
The settlement is the second multibillion-dollar settlement this month for J&J. The company, agreed November 4 to pay $2.2 billion to resolve criminal and civil probes into the marketing of Risperdal and other medicines.
According to court documents, Johnson & Johnson has agreed to settle a DePuy ASR hip replacement lawsuit, on the eve of trial. The settlement agreement remains confidential.
Johnson & Johnson subsidiary DePuy Orthopaedics has agreed to settle a DePuy ASR hip lawsuit, the first bellwether trial in a California state court consolidation of ASR cases.
This DePuy ASR case that was set to begin later in October in California state court. See my earlier reporting on secret settlement negotiations regarding the DePuy ASR implants. This is overall good news for plaintiffs that the company is beginning to take the failure allegations seriously.
The plaintiff, Leslie Caccia, had to undergo multiple revision surgeries after his Biomet ReCap Femoral Resurfacing System and M2A-Magnum metal-on-metal hip replacement system prematurely failed.
The device is the Oasys Occipito-Cervico-Thoracic System, which is designed to stabilize the junction between the occipital bone and vertebrae in the cervical spine.
Stryker has received reports that a pin that connects the tulip head to the plate body can fracture, possibly causing blood loss, nerve injury and the need for revision surgery. The FDA put its Class I designation on the recall, a notification for potentially deadly malfunctions.